Effect of certain monoamine oxidase inhibitors on isoproterenol-induced cardiac necrosis in rats.
D000818:Animals; D001794:Blood Pressure / Q000187:drug effects; D001835:Body Weight / Q000187:drug effects; D004247:DNA / Q000032:analysis; D005260:Female; D006331:Heart Diseases / Q000139:chemically induced*; D006339:Heart Rate / Q000187:drug effects; D006834:Hydrazines / Q000494:pharmacology*; D007490:Iproniazid / Q000494:pharmacology*; D007520:Isocarboxazid / Q000494:pharmacology*; D007545:Isoproterenol / Q000633:toxicity*; D008928:Mitochondria / Q000187:drug effects; D008996:Monoamine Oxidase Inhibitors / Q000494:pharmacology*; D009526:Nialamide / Q000494:pharmacology*; D009929:Organ Size / Q000187:drug effects; D010293:Pargyline / Q000494:pharmacology*; D010624:Phenelzine / Q000494:pharmacology*; D011188:Potassium / Q000032:analysis; D012313:RNA / Q000032:analysis; D051381:Rats; D012964:Sodium / Q000032:analysis; D014191:Tranylcypromine / Q000494:pharmacology*
D006834:Hydrazines; D008996:Monoamine Oxidase Inhibitors; D007520:Isocarboxazid; D014191:Tranylcypromine; D012313:RNA; D004247:DNA; D010293:Pargyline; D012964:Sodium; D007490:Iproniazid; D007545:Isoproterenol; D010624:Phenelzine; D011188:Potassium; D009526:Nialamide